Oral Ulcer
Information
- Disease name
- Oral Ulcer
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT00333749 | Completed | Phase 1 | The Effectiveness of Pasteurized Goat Milk in the Treatment of Childhood Oral Ulcer Diseases | January 2006 | December 2007 |
NCT04383236 | Completed | N/A | Probiotic Lozenges for Treatment of Recurrent Aphthous Stomatitis | December 1, 2016 | April 21, 2019 |
NCT05032248 | Completed | N/A | Uses of Tacrolimus in Behcet Disease | April 1, 2019 | December 1, 2019 |
NCT05147376 | Completed | Early Phase 1 | Effectiveness of a Curcumin Mouthwash in Preventing Traumatic Ulcers in Patients With Fixed Orthodontic Appliances | February 21, 2022 | August 7, 2023 |
NCT05413096 | Completed | Early Phase 1 | Combination of Diclofenac Potassium and Propolis in the Therapy of Oral Aphthosis | June 1, 2021 | November 1, 2022 |
NCT06379438 | Completed | N/A | Treatment of Aphtous Ulcers With Photodynamic Therapy | March 5, 2018 | March 8, 2019 |
NCT03167632 | Completed | Oral Ulcer Prevalence: Hospital-based Cross-sectional Study | August 10, 2015 | October 25, 2015 | |
NCT03239834 | Completed | Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making | September 7, 2017 | December 20, 2020 | |
NCT03633292 | Completed | Phase 4 | Aloe Vera and Chlorhexidine Against Traumatic Oral Ulcers | January 2015 | January 2018 |
NCT05449548 | Recruiting | N/A | Lenalidomide in the Treatment of Mucosal Behçet's Syndrome | April 1, 2023 | March 31, 2025 |
NCT04710888 | Unknown status | Phase 2 | Basil Extract (Ocimum Basilicum) in the Management of Recurrent Aphthous Stomatitis | January 1, 2021 | December 1, 2021 |
NCT04989049 | Unknown status | Early Phase 1 | Therapeutic Effect of Folic Acid in Healing of Oral Ulcers | September 2022 | December 2022 |
NCT05288478 | Unknown status | Phase 2 | Dose-ranging Study of Dentoxol® Mouthrinse for Managing Oral Symptoms in People With Epidermolysis Bullosa. | April 6, 2022 | March 2023 |
NCT02769494 | Withdrawn | Phase 3 | The Efficacy of Topical Mesalazine Sustained-Release Tablets in Crohn's Disease Patients With Oral Ulcer | March 2016 | January 2017 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0000155
- MedGen concept unique identifier (MedGen Concept name)
- C0149745
- MedGen unique identifier (MedGen Concept name)
- 57699
- MeSH unique ID (MeSH (Medical Subject Headings))
- D019226